About BioMedomics
BioMedomics is a company based in Durham (United States) founded in 2006. BioMedomics has raised $1.5 million across 6 funding rounds from investors including NIH and HHS. BioMedomics offers products and services including Sickle SCAN, Sickle SCAN EZ, and Infectious Disease Tests. BioMedomics operates in a competitive market with competitors including Entopsis, Tethis, GNA Biosolutions, NanoVation-GS and Hemex Health, among others.
- Headquarter Durham, United States
-
Sectors
TechnologyHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biomedomics, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.5 M (USD)
in 6 rounds
-
Latest Funding Round
Not available
-
Investors
NIH
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioMedomics
BioMedomics offers a comprehensive portfolio of products and services, including Sickle SCAN, Sickle SCAN EZ, and Infectious Disease Tests.
Rapid point-of-care test for sickle cell disease detection
Simplified test for large-scale sickle cell diagnostics
Tests for identifying pathogens and microorganisms
People of BioMedomics
Unlock access to complete
Unlock access to complete
Funding Insights of BioMedomics
BioMedomics has successfully raised a total of $1.5M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BioMedomics
BioMedomics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for BioMedomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioMedomics
Investment portfolio details for BioMedomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioMedomics
Detailed financials for BioMedomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biomedomics Comparisons
Peer comparison for BioMedomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioMedomics
BioMedomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Entopsis, Tethis, GNA Biosolutions, NanoVation-GS and Hemex Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Diagnostic devices for health monitoring are developed using specialized slides.
|
|
| Locked | Locked | Locked |
Automated solutions for liquid biopsy processing are provided.
|
|
| Locked | Locked | Locked |
Instruments and assays for molecular pathogen detection are developed.
|
|
| Locked | Locked | Locked |
Nanomaterial-based sensors for respiratory monitoring devices are developed.
|
|
| Locked | Locked | Locked |
Platform providing care devices for the detection of tropical diseases
|
|
| Locked | Locked | Locked |
Nanotube-based biosensor chips are produced for real-time medical diagnostics.
|
Detailed competitors of BioMedomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biomedomics
Complete news archive for BioMedomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioMedomics
BioMedomics was founded in 2006 and raised its 1st funding round 8 years after it was founded.
BioMedomics is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
BioMedomics is a funded company, having raised a total of $1.5M across 6 funding rounds to date.
BioMedomics was founded in 2006 in Durham, United States, within the biotechnology sector. Point-of-care diagnostic systems for blood-based disorders are created using proprietary time-resolved lateral flow immunoassay technology and a nanotube-based platform. Operations focus on assays that have received CE marking for sickle cell anemia, hemoglobin measurement, and alpha-thalassemia detection.
BioMedomics's top competitors include Hemex Health, Tethis and GNA Biosolutions.
BioMedomics offers Sickle SCAN, Sickle SCAN EZ, and Infectious Disease Tests.